In Brief: Baxter International
This article was originally published in The Gray Sheet
Executive Summary
Baxter International: Appoints Kshitij Mohan to the newly created position of corporate VP, research and technical services, with responsibility for overseeing the firm's domestic and international research and advanced product development activities. Previously, he served as VP, scientific affairs for the firm's U.S. Healthcare business. Prior to joining Baxter in 1988, Mohan held various position within FDA's device center, including director of the Office of Science and Technology and acting director of the Office of Device Evaluation...
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.